Hormonal determinants of depression and cognitive function in independently-living elders

Endocrinologia y Nutricion

Volumn 55, Issue 9, 2008, Pages 396-401

  Alfaro, Sergio Rueda ^a   Serra Prat, Mateu ^b   Palomera, Elisabet ^b   Falcón, Immaculada ^c   Cadenas, Immaculada ^c   Boquet, Xavier ^d   Burdoy, Emili ^e   Mussoll, Josep ^c   Serra, Pere ^c   Domingo Puig, Manuel ^a,b   Ayllon J ^f   Boquet, X ^f   Bosch, A ^f   Burdoy, E ^f   Cadenas, I ^f   Dordas, J ^f   Espinosa, C ^f   Falcon I ^f   Gordillo, M ^f   Merino, M J ^f   Mussoll, J ^f   Palomera, E ^f   Papiol, M ^f   Pous, E ^f   Pubill, M ^f   Puig, J ^f   Puig Domingo, M ^f   Sanahuja, J ^f   Serra, P ^f   Serra Prat, M ^f   Serrano, C ^f   Vilardebo A ^f   Villarroya, I ^f   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b Research Unit   (Spain)

^c ABS Cirera Molins   (Spain)

^d HOSPITAL DE MATARÓ   (Spain)

^e ABS Argentona   (Spain)

^f NONE

Author keywords

Aging; Cognitive function; Depression; Hormones

Indexed keywords

ESTRADIOL; ESTRONE; HYDROCORTISONE; PRASTERONE; PRASTERONE SULFATE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

ACADEMIC ACHIEVEMENT; AGED; AGING; ARTICLE; BODY MASS; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; DEPRESSION; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; NUTRITIONAL ASSESSMENT; PLASMA; SCORING SYSTEM; SEX DIFFERENCE;

EID: 57649198425     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/S1575-0922(08)75076-9     Document Type: Article

References (29)

1. Wolf OT. Cognitive functions and sex steroids. Ann Endocrinol. 2003;64:158-61.
2. Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo Study. J Clin Endocrinol Metab. 1999;84:573-7.
3. Cappola AR, Bandeen-Roche K, Wand GS, Volpato S, Fried LP. Association of IGF-I levels with muscle strength and mobility in older women. J Clin Endocrinol Metab. 2001;86:4139-46.
4. De Bruin VM, Vieira MC, Rocha MN, Viana GS. Cortisol and dehydroepiandrosterone sulfate plasma levels and their relationship to aging, cognitive function and dementia. Brain Cogn. 2002;50:316-23.
5. Janssen JA, Stolk RP, Pols HA, Grobbe DE, De Jong FH, Lamberts SW. Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroids levels. Clin Endocrinol. 1998;48:471-8.
6. Lamberts SWJ, Van den Beld AW, Van der Lely AJ. The endocrinology of aging. Science. 1997;278:419-24.
7. Mohr BA, Guay AT, O'Donnell AB, McKinley JB. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachussets Male Ageing Study. Clin Endocrinol. 2005;62:64-73.
8. Nieschlag E, Swerldloff R, Berhe HM, Gooren LJ, Kaufman JM, Legros JJ, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl. 2005;28:125-7.
9. Puig-Domingo M, Serra-Prat M, Merino MJ, Pubill M, Burdoy E, Papiol M. Successful aging in the Mataró Aging Study participants: a functional description in relation to muscle strength. Aging Clin Exp Res. 2008 [in press].
10. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J. 1965;14:61-5.
11. Serra-Prat M, Ayllon J, Burdoy Joaquin E, Mussoll Segura J, Serra Cabot P, Papiol Rufias M, et al. Validation of the Spanish version of the Modified Stanford Health Assessment Questionnaire (MSHAQ), an instrument to measure people's satisfaction at their ability to perform normal day-to-day activities. Aten Primaria. 2003;32:564-70.
12. Folstein MF, Folstein SE, McHugh PR. Mini Mental State: a practical method for grading the cognitive state patients for the clinician. J Psychiatr Res. 1975;12:189-98.
13. Hoyl MT, Alessi CA, Harker JO, Josephson KR, Pietruszka FM, Koelfgen M, et al. Development and testing of a five-item version of the Geriatric Depression Scale. J Am Geriatr Soc. 1999;47:873-8.
14. Lupien SJ, Gaudreau S, Tchiteya BM, Maheu F, Sharma S, Nair NP, et al. Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J Clin Endocrinol Metab. 1997;82:2070-5.
15. Seeman TE, McEwen BS, Singer BH, Albert MS, Rowe JW. Increase in urinary cortisol excretion and memory declines: McArthur studies on successful aging. JClin Endocrinol Metab. 1997;82:2458-65.
16. Kalmijn S, Launer LJ, Stolk RP, De Jong FH, Pols HA, Hofman A, et al. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. J Clin Endocrinol Metab. 1998;83:3487-92.
17. Van Rossum EF, Feelders RA, Van den Beld AW, Uitterlinden AG, Janssen JA, Ester W, et al. Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. Am J Med. 2004;117:158-62.
18. Van Rossum EF, Russcher H, Lamberts SW. Genetic polymorphisms and multifactorial diseases: facts and fallacies revealed by the glucocorticoid receptor gene. Trends Endocrinol Metab. 2005;16:445-50.
19. Gurnell EM, Chatterjee VK. Dehydroepiandrosterone replacement therapy. Eur J Endocrinol. 2001;145:103-6.
20. Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomised, double blind trial. J Clin Endocrinol Metab. 2000;85:4650-6.
21. Barrett-Connor E, Von Muhlen D, Laughlin GA, Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc. 1999;47:685-91.
22. Bologa L, Sharma J, Roberts E. Dehydroepiandrosterone, and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J Neurosci Res. 1987;17:225-34.
23. Sapolky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci. 1990;10:2897-902.
24. Tenofer JC. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992;75:1092-8.
25. Wang C, Eyre DR, Clark R, Kleinberg D, Newman C, Iranmanesh A, et al. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption and increases bone formation markers in hypogonadal men. J Clin Endocrinol Metab. 1996;80:3654-62.
26. Brill KT, Weltman AL, Gentili A, Patrie JT, Fryburg DA, Hanks JB, et al. Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J Clin Endocrinol Metab. 2002;87:5649-57.
27. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355:1647-59.
28. Aleman A, Verhaar HJ, De Haan EH, De Vries WR, Samson MM, Drent ML, et al. Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab. 1999;84:471-5.
29. Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo Study. J Clin Endocrinol Metab. 1999;84:2573-7.